These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24803202)

  • 1. Incorporating the new lipid guidelines into practice.
    Spear S
    JAAPA; 2014 Jun; 27(6):11. PubMed ID: 24803202
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipids: new guidelines, intensive treatment, and future directions.
    Jones PH
    Tex Heart Inst J; 2006; 33(2):180-3. PubMed ID: 16878620
    [No Abstract]   [Full Text] [Related]  

  • 3. The Canadian lipid guidelines are difficult to model quantitatively.
    Holmes DT; Frohlich JJ
    Can J Cardiol; 2008 Aug; 24(8):621. PubMed ID: 18697284
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetic dyslipidemia: a practical guide to therapy.
    Tovar JM; Bazaldua OV; Loffredo A
    J Fam Pract; 2008 Jun; 57(6):377-88. PubMed ID: 18544321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving concepts on benefits and risks associated with therapeutic strategies to raise HDL.
    Shah PK
    Curr Opin Cardiol; 2010 Nov; 25(6):603-8. PubMed ID: 20827180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Only a minority of patients referred for elective coronary artery bypass surgery have risk factors diagnosed and treated according to established guidelines.
    Anderson RE; Brismar K; Ivert T
    Diab Vasc Dis Res; 2007 Jun; 4(2):112-6. PubMed ID: 17654444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatin.
    Shioji K; Izuhara M; Mitsuoka H; Uegaito T; Matsuda M;
    Cardiovasc Ther; 2014 Jun; 32(3):97-104. PubMed ID: 24456217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary Artery Calcium and Shared Decision Making.
    Hecht HS; Shaw LJ; Chandrashekhar Y; Narula J
    JACC Cardiovasc Imaging; 2016 May; 9(5):637-9. PubMed ID: 27151526
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipid-lowering medications: what the new guidelines and data mean to women.
    Schwartz JB
    J Gend Specif Med; 2001; 4(2):9-13. PubMed ID: 11480105
    [No Abstract]   [Full Text] [Related]  

  • 10. It's time for CHUMP to change.
    Mejia V; Carver JR
    J Invasive Cardiol; 2005 Oct; 17(10):521. PubMed ID: 16204744
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of a treatment optimization algorithm involving statin-ezetimibe combination aids in achievement of guideline-based low-density lipoprotein targets in patients with dyslipidemia at high vascular risk Guideline-based Undertaking to Improve Dyslipidemia Management in Canada (GUIDANC).
    Katz PM; Mendelsohn AA; Goodman SG; Langer A; Teoh H; Leiter LA
    Can J Cardiol; 2011; 27(2):138-45. PubMed ID: 21459260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.
    Robinson JG
    Future Cardiol; 2014 Mar; 10(2):149-52. PubMed ID: 24762237
    [No Abstract]   [Full Text] [Related]  

  • 13. Viewpoint: Terje R. Pedersen, MD, PhD. Interview by Robert Short.
    Pedersen TR
    Circulation; 2007 Mar; 115(12):f51-2. PubMed ID: 17393574
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dyslipidemias and statins: from guidelines to clinical practice. An updated review of the literature].
    Lucchi T; Vergani C
    G Ital Cardiol (Rome); 2014 Mar; 15(3):149-60. PubMed ID: 24770428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Questioning the benefits of statins.
    Mazowita G
    CMAJ; 2005 Nov; 173(10):1210; author reply 1210. PubMed ID: 16275979
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of dyslipidemia in renal disease and transplantation.
    Zolezzi M
    Saudi J Kidney Dis Transpl; 2006 Jun; 17(2):129-36. PubMed ID: 16903617
    [No Abstract]   [Full Text] [Related]  

  • 17. Shifting views on lipid lowering therapy.
    Krumholz HM; Hayward RA
    BMJ; 2010 Jul; 341():c3531. PubMed ID: 20667950
    [No Abstract]   [Full Text] [Related]  

  • 18. [The discussion on target goals in lipid reduction is still going on. The Expert Committee--a block for current cardiovascular prevention].
    Olsson AG
    Lakartidningen; 2011 Nov 23-29; 108(47):2442-3. PubMed ID: 22468387
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical practice guidelines for the management of dyslipidemia in chronic kidney disease].
    Shoji T
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1267-75. PubMed ID: 24288962
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of statin therapy in patients with lower vascular risk.
    Keech AC; Fulcher JR; Simes J
    Med J Aust; 2012 Aug; 197(3):130-1. PubMed ID: 22860773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.